We have recently reported that such dysfunction derives, at least in part, from alterations of aryl-hydrocarbon-receptor (AhR) signaling (44), suggesting that modulation of this pathway might be deployed to correct immunoregulatory defects while boosting Treg immunity in AIH. Here, AHR is linked to autoimmune hepatitis.